Abalos Therapeutics raised €43M in a Series A round in Oct 2021. The company is based in Essen, Germany. Investors in the round: Boehringer Ingelheim, Coparion, Gründerfonds Ruhr and 5 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €43M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
